Article
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
2021-01-14
Abstract excerpt
SARS-CoV-2 entry into host cells is orchestrated by the spike (S) glycoprotein that contains an immunodominant receptor-binding domain (RBD) targeted by the largest fraction of neutralizing antibodies (Abs) in COVID-19 patient plasma. Little is known about neutralizing Abs binding to epitopes outside the RBD and their contribution to protection. Here, we describe 41 human monoclonal Abs (mAbs) derived from memory...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c26d1b09-b1bb-5fab-a2d6-f59c96b524f0
- DOI
- 10.1101/2021.01.14.426475
